Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Telkom Indonesia
TLK
$14.4B
| $55.3M | 0.08% |
1,772,600
+321,300
| +22% | +$9.49M |
|
327
Republic Services
RSG
$65.9B
| $55M | 0.08% |
875,000
+671,300
| +330% | +$40.2M |
|
328
Credicorp
BAP
$30B
| $54.9M | 0.08% |
335,900
+221,600
| +194% | +$36.4M |
|
|
X
329
DELISTED
US Steel
X
| $54.8M | 0.08% |
1,620,100
-4,034,900
| -71% | -$143M |
|
|
VALE.P
330
DELISTED
Vale S A
VALE.P
| $54.7M | 0.08% |
6,090,599
+4,140,499
| +212% | +$38.9M |
|
331
Kimco Realty
KIM
$16.1B
| $54.3M | 0.08% |
2,456,829
+1,657,434
| +207% | +$39.8M |
|
|
VVC
332
DELISTED
Vectren Corporation
VVC
| $54.2M | 0.08% |
924,900
+93,100
| +11% | +$5.16M |
|
333
RenaissanceRe
RNR
$13.2B
| $54.1M | 0.08% |
374,215
+55,300
| +17% | +$7.91M |
|
|
SPLS
334
DELISTED
Staples Inc
SPLS
| $53.8M | 0.08% |
6,140,117
+243,984
| +4% | +$2.2M |
|
335
Blackstone
BX
$110B
| $53.4M | 0.07% |
1,798,700
+664,400
| +59% | +$20M |
|
336
Henry Schein
HSIC
$9.94B
| $53.3M | 0.07% |
799,695
-409,020
| -34% | -$26.6M |
|
337
Air Products & Chemicals
APD
$68.9B
| $53.1M | 0.07% |
392,600
-179,200
| -31% | -$25.3M |
|
338
Hanover Insurance
THG
$7.73B
| $53M | 0.07% |
588,900
+61,700
| +12% | +$5.46M |
|
|
CVA
339
DELISTED
Covanta Holding Corporation
CVA
| $52.7M | 0.07% |
3,356,216
-268,600
| -7% | -$4.22M |
|
340
Ormat Technologies
ORA
$7.04B
| $52.6M | 0.07% |
921,157
+179,900
| +24% | +$9.97M |
|
341
Cinemark Holdings
CNK
$4.25B
| $52.4M | 0.07% |
1,182,800
-443,200
| -27% | -$18.7M |
|
342
Viavi Solutions
VIAV
$9.47B
| $52.2M | 0.07% |
4,871,744
-1,194,944
| -20% | -$11.6M |
|
343
WSFS Financial
WSFS
$4.14B
| $52.1M | 0.07% |
1,134,814
+38,700
| +4% | +$1.76M |
|
344
Pricesmart
PSMT
$5.33B
| $52M | 0.07% |
563,800
+85,600
| +18% | +$7.51M |
|
345
Kearny Financial
KRNY
$600M
| $51.8M | 0.07% |
3,441,018
+318,497
| +10% | +$4.81M |
|
346
REX American Resources
REX
$1.43B
| $51.5M | 0.07% |
3,411,600
+18,000
| +0.5% | +$255K |
|
347
Leidos
LDOS
$17.7B
| $51.4M | 0.07% |
1,005,350
-477,131
| -32% | -$24.6M |
|
348
Portland General Electric
POR
$5.69B
| $51.3M | 0.07% |
1,155,300
+248,300
| +27% | +$10.9M |
|
|
BUFF
349
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $51.2M | 0.07% |
2,226,700
+1,045,700
| +89% | +$25.7M |
|
|
JNPR
350
DELISTED
Juniper Networks
JNPR
| $50.7M | 0.07% |
1,822,891
+34,300
| +2% | +$957K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.